title: Metabolic sequelae associated with androgen deprivation therapy for prostate cancer.
abstract: OBJECTIVE
  To summarize the metabolic alterations associated with androgen deprivation therapy (ADT) for prostate cancer and to evaluate the evidence linking ADT with an increased risk of diabetes and cardiovascular disease.
  
  
  RESULTS
  ADT by either bilateral orchiectomy or treatment with gonadotropin-releasing hormone agonists causes changes in body composition, alterations in lipid profiles, and decreased insulin sensitivity. The spectrum of metabolic changes during ADT is distinct from classically described metabolic syndrome. Population-based, linked cancer registry studies have consistently reported significant associations between ADT and greater risk for diabetes mellitus. Some but not all studies have reported a link between ADT and cardiovascular disease risk. Most studies have reported no increase in cardiovascular mortality following ADT.
  
  
  CONCLUSIONS
  ADT appears causally associated with diabetes mellitus. ADT is also linked to cardiovascular morbidity, although there is less evidence that this relationship is causal.
authors.affiliation: Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
authors.forename: Jason E
authors.initials: JE
authors.lastname: Faris
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Smith
mesh_terms: D000728:Androgens / Q000172:deficiency*; D002318:Cardiovascular Diseases / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000453:epidemiology; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000728:Androgens; D007987:Gonadotropin-Releasing Hormone
references.citation: Ann N Y Acad Sci. 2000 May;904:437-48
references.pmid: 10865787
references.citation: Metabolism. 1990 Dec;39(12):1314-9
references.pmid: 2123281
references.citation: J Clin Endocrinol Metab. 2005 May;90(5):2618-23
references.pmid: 15687322
references.citation: J Clin Endocrinol Metab. 2006 Apr;91(4):1305-8
references.pmid: 16434464
references.citation: J Gen Intern Med. 2009 Nov;24 Suppl 2:S389-94
references.pmid: 19838837
references.citation: J Clin Endocrinol Metab. 2006 Mar;91(3):843-50
references.pmid: 16394089
references.citation: Cancer. 2002 Nov 15;95(10):2136-44
references.pmid: 12412167
references.citation: JAMA. 2009 Nov 11;302(18):1993-2000
references.pmid: 19903920
references.citation: Circulation. 2007 Jan 30;115(4):450-8
references.pmid: 17190864
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2420-5
references.pmid: 17557956
references.citation: JAMA. 1986 Nov 28;256(20):2823-8
references.pmid: 3773199
references.citation: N Engl J Med. 1984 Nov 15;311(20):1281-6
references.pmid: 6436700
references.citation: J Clin Oncol. 2004 Jun 1;22(11):2141-9
references.pmid: 15169800
references.citation: J Urol. 2009 May;181(5):1998-2006; discussion 2007-8
references.pmid: 19286225
references.citation: Lancet. 2007 Dec 1;370(9602):1829-39
references.pmid: 18061058
references.citation: Urology. 2004 Apr;63(4):742-5
references.pmid: 15072892
references.citation: Br J Urol. 1997 Feb;79(2):235-46
references.pmid: 9052476
references.citation: Eur J Endocrinol. 2009 May;160(5):839-46
references.pmid: 19174534
references.citation: Eur Heart J. 2000 Jun;21(11):890-4
references.pmid: 10806012
references.citation: JAMA. 2008 Nov 12;300(18):2142-52
references.pmid: 19001625
references.citation: J Clin Endocrinol Metab. 2009 Jul;94(7):2482-8
references.pmid: 19401373
references.citation: Circulation. 1998 Aug 4;98(5):398-404
references.pmid: 9714089
references.citation: Clin Endocrinol (Oxf). 2002 Jun;56(6):779-86
references.pmid: 12072048
references.citation: J Urol. 2006 Jan;175(1):136-9; discussion 139
references.pmid: 16406890
references.citation: Am J Cardiol. 2006 Jan 16;97(2A):3A-11A
references.pmid: 16442931
references.citation: Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):719-24
references.pmid: 15936551
references.citation: J Clin Endocrinol Metab. 1997 Feb;82(2):407-13
references.pmid: 9024227
references.citation: J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24
references.pmid: 17925537
references.citation: BJU Int. 2006 Nov;98(5):973-8
references.pmid: 16879443
references.citation: Circulation. 2005 Jul 19;112(3):332-40
references.pmid: 16009799
references.citation: Urology. 2007 Dec;70(6):1104-8
references.pmid: 18158027
references.citation: J Natl Cancer Inst. 2010 Jan 6;102(1):39-46
references.pmid: 19996060
references.citation: J Clin Oncol. 2005 Nov 1;23(31):7897-903
references.pmid: 16258089
references.citation: J Clin Oncol. 2009 Jul 20;27(21):3452-8
references.pmid: 19506162
references.citation: Cancer. 2008 May 15;112(10):2188-94
references.pmid: 18348297
references.citation: N Engl J Med. 1996 Apr 11;334(15):952-7
references.pmid: 8596596
references.citation: J Am Coll Cardiol. 2006 Nov 7;48(9):1800-7
references.pmid: 17084253
references.citation: J Clin Oncol. 2009 Jan 1;27(1):92-9
references.pmid: 19047297
references.citation: Diabetes Care. 2005 Sep;28(9):2289-304
references.pmid: 16123508
references.citation: Eur J Med. 1992 Oct;1(6):329-36
references.pmid: 1341460
references.citation: Arch Intern Med. 2007 Jun 25;167(12):1252-60
references.pmid: 17592098
references.citation: JAMA. 2004 Aug 18;292(7):821-7
references.pmid: 15315996
references.citation: Eur J Endocrinol. 2006 Jun;154(6):899-906
references.pmid: 16728551
references.citation: Diabetes Care. 2005 Jul;28(7):1636-42
references.pmid: 15983313
references.citation: Cancer. 2005 Apr 15;103(8):1615-24
references.pmid: 15742331
references.citation: J Urol. 2002 Jun;167(6):2361-7; discussion 2367
references.pmid: 11992038
references.citation: J Urol. 1995 Jul;154(1):100-4
references.pmid: 7539852
references.citation: J Clin Oncol. 2006 Aug 20;24(24):3979-83
references.pmid: 16921050
references.citation: Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):693-700
references.pmid: 18827572
references.citation: J Clin Endocrinol Metab. 1996 Dec;81(12):4358-65
references.pmid: 8954042
references.citation: BJU Int. 2008 Dec;102(11):1509-14
references.pmid: 18727614
references.citation: J Clin Oncol. 2006 Apr 20;24(12):1868-76
references.pmid: 16622261
references.citation: J Clin Endocrinol Metab. 1998 Jun;83(6):1886-92
references.pmid: 9626114
references.citation: JAMA. 2002 Dec 4;288(21):2709-16
references.pmid: 12460094
references.citation: JAMA. 2005 Jul 13;294(2):238-44
references.pmid: 16014598
references.citation: J Androl. 2009 Jan-Feb;30(1):23-32
references.pmid: 18772488
references.citation: Cancer. 2005 Oct 15;104(8):1633-7
references.pmid: 16116596
references.citation: N Engl J Med. 1997 Jul 31;337(5):295-300
references.pmid: 9233866
references.citation: Can J Urol. 2005 Feb;12(1):2547-52
references.pmid: 15777493
references.citation: J Endocrinol Invest. 1999;22(5 Suppl):110-6
references.pmid: 10442580
references.citation: Cancer. 2007 Oct 1;110(7):1493-500
references.pmid: 17657815
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: J Clin Oncol. 2008 Feb 1;26(4):585-91
references.pmid: 18172188
references.citation: Eur Urol. 1995;27(4):274-9
references.pmid: 7544732
references.citation: Circulation. 2007 Jul 3;116(1):39-48
references.pmid: 17576866
references.citation: Br J Urol. 1997 Jun;79(6):933-41
references.pmid: 9202563
references.citation: Diabetes Care. 2000 Apr;23(4):490-4
references.pmid: 10857940
references.citation: Prostate. 1996 Oct;29(4):243-8
references.pmid: 8876707
references.citation: N Engl J Med. 2005 Jan 13;352(2):154-64
references.pmid: 15647578
references.citation: J Clin Oncol. 1997 Mar;15(3):1013-21
references.pmid: 9060541
references.citation: J Clin Endocrinol Metab. 2001 Sep;86(9):4261-7
references.pmid: 11549659
references.citation: J Natl Cancer Inst. 2000 Apr 19;92(8):613-21
references.pmid: 10772678
references.citation: Clin Chem. 2005 Jun;51(6):931-8
references.pmid: 15746300
references.citation: J Urol. 2004 Jun;171(6 Pt 1):2285-90
references.pmid: 15126804
references.citation: J Clin Endocrinol Metab. 1999 Aug;84(8):2647-53
references.pmid: 10443654
references.citation: Cancer. 1998 Sep 15;83(6):1180-8
references.pmid: 9740084
references.citation: N Engl J Med. 1999 Dec 9;341(24):1781-8
references.pmid: 10588962
references.citation: J Clin Endocrinol Metab. 2002 Feb;87(2):599-603
references.pmid: 11836291
references.citation: Eur Urol. 2008 Oct;54(4):816-23
references.pmid: 18243498
references.citation: J Clin Oncol. 2006 Sep 20;24(27):4448-56
references.pmid: 16983113
references.citation: Clin Sci (Lond). 2003 Feb;104(2):195-201
references.pmid: 12546642
references.citation: Stroke. 1998 Sep;29(9):1860-6
references.pmid: 9731609
references.citation: J Clin Endocrinol Metab. 2008 Jan;93(1):68-75
references.pmid: 17911176
references.citation: Urology. 1986 Jan;27(1 Suppl):21-8
references.pmid: 3079935